Viewing Study NCT05742594


Ignite Creation Date: 2025-12-25 @ 1:32 AM
Ignite Modification Date: 2025-12-25 @ 11:45 PM
Study NCT ID: NCT05742594
Status: COMPLETED
Last Update Posted: 2023-06-02
First Post: 2023-02-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Four Different Oral Tablet Formulations of Lazertinib (JNJ-73841937) in Healthy Adult Participants
Sponsor: Janssen Research & Development, LLC
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2023-01-03
Start Date Type: ACTUAL
Primary Completion Date: 2023-03-31
Primary Completion Date Type: ACTUAL
Completion Date: 2023-04-03
Completion Date Type: ACTUAL
First Submit Date: 2023-02-15
First Submit QC Date: None
Study First Post Date: 2023-02-24
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-06-01
Last Update Post Date: 2023-06-02
Last Update Post Date Type: ACTUAL